PPA
VOR icon

Parametric Portfolio Associates’s Vor Biopharma VOR Stock Holding History

Parametric Portfolio Associates’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,083
Closed -$252K – 3770
2021
Q4 		$252K Sell
1,083
-5,768
-84% -$1.66M ﹤0.01% 3337
2021
Q3 		$2.15M Buy
6,851
+2,569
+60% +$764K ﹤0.01% 2408
2021
Q2 		$1.6M Buy
+4,282
New +$2.11M ﹤0.01% 2552

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Parametric Portfolio Associates's VOR Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Vor Biopharma (VOR) in Q1 2022, closing a stake of 1,083 shares — an estimated $252K sold.

Parametric Portfolio Associates first reported a position in VOR in Q2 2021 and held it in 3 quarters. The position peaked at $2.15M in Q3 2021. 58 funds tracked by Wall St. Rank hold VOR as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Vor Biopharma position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 1,083 Vor Biopharma shares in Q1 2022, an estimated $252K.
  • Parametric Portfolio Associates first reported a position in Vor Biopharma in Q2 2021 and held it in 3 quarters.
  • Parametric Portfolio Associates's Vor Biopharma position peaked at $2.15M in Q3 2021.
  • 58 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.